Trial | FIGARO-DKD (N = 7437) | FIDELIO (N = 5734) | CREEDENCE (N = 4401) | DAPA-CKD (N = 4304) | IDNT (N = 1715) | P VALUE |
Year Published | 2021 | 2020 | 2019 | 2020 | 2001 |
|
DM% | 100 | 100 | 100 | 67 | 100 | <0.00001 |
Mean eGFR (ml/min) or Cr (mg/dL) | 68 | 44 | 56 | 43 | 1.67 | 0.009 |
GFR range (mL/min) | 25 - 90 | 25 - 60 | 30 - 90 | 25 - 75 | N/A |
|
Proteinuria (g/d) | 0.31 | 0.83 | 0.92 | 0.95 | 2.9 | 0.028 |
HbA1c | 7.7 | 7.7 | 8.3 | N/A | 8.1 |
|
Age | 64 | 65 | 63 | 62 | 59 | <0.00001 |
M/F | 69/31 | 69/31 | 66/34 | 67/33 | 67/33 |
|
W/B/A | 72/3.5/20 | 63/5/25 | 67/5/20 | 52/5/35 | 76/11/4 |
|
ACE/ARB | 100 | 100 | 100 | 100 | 50 |
|
SGLT2 USE (%) | 8 | 4.6 | 100 | 100 | 0 |
|
Renal Outcome RR (%) | 13 | 18 | 30 | 39 | 20 | <0.0001 |
Trial length (mos) | 41 | 30 | 30 | 28 | 30 | <0.00001 |